Jinla where are you getting your facts from?
The announcement last week stated the next trial will cost under $1.5m, and the company has those funds currently in the bank along with the imminent sale of the surgical business.
I cannot see the point of completing 2 more trials after the IIa results announced last week. It would be an uneccesary expense and delay the time to market. Give the management team a little more credit than that IMO
clyde r u still with us??, page-41
Add EMS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.523M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 227968 | 1 |
View Market Depth
| Last trade - 16.12pm 19/07/2024 (20 minute delay) ? |
| EMS (ASX) Chart |
Day chart unavailable